Ameritas Investment Partners’s Insmed INSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-7,788
| Closed | -$1.27M | – | 3252 |
|
|
2026
Q1 | $1.27M | Buy |
7,788
+78
| +1% | +$12K | 0.04% | 515 |
|
|
2025
Q4 | $1.34M | Buy |
+7,710
| New | +$1.41M | 0.04% | 487 |
|
|
2025
Q2 | – | Sell |
-17,551
| Closed | -$1.34M | – | 3265 |
|
|
2025
Q1 | $1.34M | Hold |
17,551
| – | – | 0.05% | 499 |
|
|
2024
Q4 | $1.21M | Buy |
17,551
+1,630
| +10% | +$117K | 0.04% | 559 |
|
|
2024
Q3 | $1.16M | Buy |
15,921
+703
| +5% | +$51.9K | 0.04% | 573 |
|
|
2024
Q2 | $1.02M | Buy |
15,218
+1,432
| +10% | +$55.5K | 0.04% | 605 |
|
|
2024
Q1 | $374K | Sell |
13,786
-523
| -4% | -$14.6K | 0.01% | 925 |
|
|
2023
Q4 | $443K | Buy |
14,309
+1,212
| +9% | +$31.4K | 0.02% | 845 |
|
|
2023
Q3 | $331K | Buy |
13,097
+2,280
| +21% | +$52.1K | 0.01% | 916 |
|
|
2023
Q2 | $228K | Hold |
10,817
| – | – | 0.01% | 1056 |
|
|
2023
Q1 | $184K | Hold |
10,817
| – | – | 0.01% | 1147 |
|
|
2022
Q4 | $231K | Buy |
10,817
+1,598
| +17% | +$30.9K | 0.01% | 1053 |
|
|
2022
Q3 | $198K | Hold |
9,219
| – | – | 0.01% | 1063 |
|
|
2022
Q2 | $181K | Hold |
9,219
| – | – | 0.01% | 1129 |
|
|
2022
Q1 | $217K | Hold |
9,219
| – | – | 0.01% | 1137 |
|
|
2021
Q4 | $251K | Buy |
9,219
+405
| +5% | +$11.6K | 0.01% | 1087 |
|
|
2021
Q3 | $243K | Buy |
8,814
+579
| +7% | +$15.2K | 0.01% | 1073 |
|
|
2021
Q2 | $234K | Hold |
8,235
| – | – | 0.01% | 1127 |
|
|
2021
Q1 | $280K | Sell |
8,235
-392
| -5% | -$15K | 0.01% | 991 |
|
|
2020
Q4 | $287K | Hold |
8,627
| – | – | 0.01% | 949 |
|
|
2020
Q3 | $277K | Sell |
8,627
-317
| -4% | -$9.11K | 0.01% | 891 |
|
|
2020
Q2 | $246K | Buy |
8,944
+1,159
| +15% | +$27.5K | 0.01% | 921 |
|
|
2020
Q1 | $125K | Hold |
7,785
| – | – | 0.01% | 1154 |
|
|
2019
Q4 | $186K | Buy |
7,785
+380
| +5% | +$7.73K | 0.01% | 1135 |
|
|
2019
Q3 | $131K | Buy |
7,405
+1,058
| +17% | +$20.4K | 0.01% | 1307 |
|
|
2019
Q2 | $162K | Hold |
6,347
| – | – | 0.01% | 1181 |
|
|
2019
Q1 | $185K | Hold |
6,347
| – | – | 0.01% | 1096 |
|
|
2018
Q4 | $83K | Hold |
6,347
| – | – | ﹤0.01% | 1507 |
|
|
2018
Q3 | $128K | Hold |
6,347
| – | – | 0.01% | 1379 |
|
|
2018
Q2 | $150K | Hold |
6,347
| – | – | 0.01% | 1258 |
|
|
2018
Q1 | $143K | Hold |
6,347
| – | – | 0.01% | 1266 |
|
|
2017
Q4 | $198K | Buy |
6,347
+1,000
| +19% | +$29.5K | 0.01% | 1090 |
|
|
2017
Q3 | $66K | Hold |
5,347
| – | – | ﹤0.01% | 1700 |
|
|
2017
Q2 | $92K | Hold |
5,347
| – | – | ﹤0.01% | 1511 |
|
|
2017
Q1 | $94K | Buy |
+5,347
| New | +$82.5K | ﹤0.01% | 1461 |
|
Other funds holding INSM
BBA
DGM
OAG
Ameritas Investment Partners's INSM Position: Q2 2026 in Review
Ameritas Investment Partners sold out of Insmed (INSM) in Q2 2026, closing a stake of 7,788 shares — an estimated $1.27M sold.
Ameritas Investment Partners first reported a position in INSM in Q1 2017 and held it in 35 quarters. The position peaked at $1.34M in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.
- Ameritas Investment Partners reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
- Ameritas Investment Partners sold 7,788 Insmed shares in Q2 2026, an estimated $1.27M.
- Ameritas Investment Partners first reported a position in Insmed in Q1 2017 and held it in 35 quarters.
- Ameritas Investment Partners's Insmed position peaked at $1.34M in Q4 2025.
- 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.
Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.